We are on a mission to elevate patient care in breast cancer and beyond.

With nearly 2 million new diagnoses annually, breast cancer is the second most prevalent cancer worldwide. Up to 30% of people diagnosed with breast cancer ultimately develop metastatic disease.

Like many people and families, much of our team has been personally affected by this disease, fueling our collective passion to create more effective, safe, and convenient treatments to help people living with cancer feel better, longer. Meet our team of oncology experts with a track record of bringing disruptive new therapies to market.

Our Team leadership board of directors
leadership
board of directors
leadership
Sean P. Bohen, M.D., Ph.D. President and CEO
cross
Shane Kovacs Chief Operating and Financial Officer
cross
Shawnte M. Mitchell, J.D. Chief Legal Officer and Corporate Secretary
cross
David C. Myles, Ph.D. Chief Discovery and Non-Clinical Development Officer
cross
Naseem Zojwalla, M.D. Chief Medical Officer
cross
Julie Dexter Senior Vice President and Head of People
cross
Angelos Dovletoglou, Ph.D. Senior Vice President, CMC and Supply Chain
cross
Richard Hernandez Senior Vice President, Clinical Development Operations
cross
Kamesh Kuchimanchi, Ph.D. Senior Vice President, Regulatory Affairs and Quality Assurance
cross
Mark Shilkrut, M.D., Ph.D. Senior Vice President, Clinical Development
cross
Sasha Austin, CPA Vice President, Finance and Controller
cross
Yolande Du Toit, MD Vice President, Medical Affairs
cross
Kristin Lanzi Vice President, Information Technology
cross
Courtney O'Konek Vice President, Corporate Communications
cross
Gopinath Palanisamy, DVM, Ph.D., DACVP Vice President, Pre-Clinical Pharmacology and Toxicology
cross
Amoli Pandya, J.D. Vice President, Corporate Law
cross
Ronald E. Savage, Ph.D. Vice President, Clinical Pharmacology
cross
Kate Swearingen Vice President, Program Management
cross
Margaret Tonda, PharmD Vice President, Clinical Science
cross
Ganesh Waghmare, M.D., MPH Vice President, Drug Safety and Pharmacovigilance
cross
James Wagner, J.D. Vice President, Legal Counsel
cross
Rachel Wei, Ph.D. Vice President, Biostatistics
cross
Sean P. Bohen, M.D., Ph.D. President and CEO
cross
Ian Clark Chairman of the Board
cross
Cindy Butitta Member
cross
Scott Garland Member
cross
Cyrus Harmon, Ph.D. Member
cross
Sandra J. Horning, M.D., FACP, FASCO Member
cross
Gorjan Hrustanovic, Ph.D. Member
cross
Yi Larson, MBA Member
cross
Andy Rappaport Member
cross
Graham Walmsley, M.D., Ph.D. Member
cross